EXOME

all the information, none of the junk | biotech • healthcare • life sciences

McGuire, Bosley, Watson, & More at Our Health Summit—Register Today

Xconomy Boston — 

We have just over three weeks to go before our third annual Healthcare Summit here in Boston. And if you act quickly, you can take advantage of our Procrastinator’s Special and save $100 off regular registration…if you don’t put it off, that is.

The agenda is live—and you can see for yourself the fantastic afternoon that is in store at the Broad Institute in Cambridge’s Kendall Square on November 17. This special event will examine new advances in areas like gene editing that are on the cutting edge of science, the latest thinking about how to live a longer, healthier life, what’s in store for consumers looking to improve their healthcare experience, and more.

Opening the afternoon will be a chat between Tillman Gerngross of Dartmouth University and Terry McGuire of Polaris Partners. The two legends of New England life sciences have formed several startups together and will be sharing their experiences about how collaboration helps build great companies.

But that’s just the beginning of this broad-ranging afternoon that includes leading speakers from not just the Boston area, but around the Xconomy network. From Texas comes Lynda Chin, a physician-scientist who recently was named chief innovation officer for health affairs for the University of Texas system. Her ambitious topic: Transforming Medicine. From Madison, WI, we will have the legendary scientist, inventor, and serial entrepreneur Thomas “Rock” Mackie, whose latest startup is called HealthMyne, which does real time imaging informatics for cancer care. He will be joining John McDonough, CEO of diagnostics innovator T2 Biosystems, in a chat called The Brave New World of Diagnostics and Data, which will be moderated by Laurie Halloran of Halloran Consulting.

Katrine Bosley, CEO of gene editing company Editas Medicine, will team up with Sheila Dodge director of Genomic Platform Operations and Development at the Broad Institute, for a session on the Genomics and Gene Editing Revolutions. We’ll also hear from MIT biologist Leonard Guarente, a specialist on health and aging—and two panels packed with great innovators. See below for the lineups:

Targeting Wellness: New Models of Collaboration

John Brownstein, Chief Innovation Officer, Boston Children’s Hospital
Christopher Loose, Executive Director, Yale Center for Biomedical and Interventional Technology
Ben Wiegand, Head, Disease Interceptor Accelerator, Janssen/Johnson & Johnson

Health IT for Consumers

Rebecca Palm, Co-founder and Chief Strategy Officer, CoPatient
Elliot Cohen, Co-founder and Chief Technology Officer, PillPack
Jacob Sattelmair, Co-founder and CEO, Wellframe
David Frankel, Managing Partner, Founder Collective (moderator)

Closing out the day will be a unique session featuring Watson Health (in the form of CMO Stephen Gold). We have some special things in store for this session—and you won’t want to miss it.

As always, our goal at the summit is to provide a unique look across the entire healthcare continuum—from basic science to the consumer. Again, you have to act quickly to save for this must-attend event—so check it out get your tickets here.